Zifcasiran
Zifcasiran (ADS-007; ARO HIF2) is an siRNA synthetic double-stranded RNAi trigger. Zifcasiran sodium selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). Zifcasiran sodium engages the cell's RNAi machinery to target HIF2α (EPAS1) mRNA for degradation, thereby reducing the amount of free HIF2α mRNA available for translation.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2437257-11-7
- Formule: C737H972F20N211O349P43S8
- Masse moléculaire:20339.13
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2437257-11-7
-
Masse moléculaire 20339.13
-
Formule C737H972F20N211O349P43S8
-
SMILES
[Zifcasiran]
-
Synonyms
ADS-007; ARO HIF2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Zifcasiran
- 2437257-11-7
- ADS-007
- ARO HIF2
- ADS007
- ADS 007
- ARO HIF2
- ARO HIF 2
- ARO HIF-2
- Small Interfering RNA (siRNA)
- HIF/HIF Prolyl-Hydroxylase
- RNAi machinery
- HIF2α
- ccRCC tumorgrafts
- clear cell renal cell carcinoma
- HIF2α mRNA
- αvβ3 integrin ligand
- erythropoietin
- HIF1α mRNA
- nude mice
- HIF2α protein
- Inhibitor
- inhibitor
- inhibit